7 Facts About Menopause and Gallbladder Disease Every Woman Should Know
Nobody warned about the gallbladder. Hot flashes, yes. Sleep problems, absolutely. But when the right-side pain showed up after a fatty meal, the last thing anyone thought to connect it to was the menopause transition. That gap in standard menopause education is exactly why this page exists.
Learn more about Rose →Estrogen Directly Affects How Bile Is Made
Estrogen increases the amount of cholesterol secreted into bile while simultaneously reducing the bile acids that normally keep cholesterol dissolved — a combination that makes bile significantly more likely to form solid crystals, or gallstones. This effect is dose-dependent, meaning higher estrogen levels (including from hormone therapy) amplify the change. The gallbladder, in other words, is not immune to the hormonal environment — it is actively shaped by it.
Gallbladder Motility Slows When Estrogen Drops
Beyond bile composition, estrogen also plays a role in gallbladder contractility — how efficiently the organ empties after a meal. As estrogen declines during perimenopause, gallbladder emptying can slow, allowing bile to pool and concentrate for longer periods, which raises the odds of cholesterol crystallising into stones. This sluggish emptying, known as biliary stasis, is one of the key mechanisms linking menopause to increased gallstone formation.
Women Are Already at Higher Risk Than Men — and Menopause Widens That Gap
Gallstone disease is roughly twice as common in women as in men throughout adult life, largely because of the effects of estrogen and progesterone on bile. After menopause, the risk continues to climb: epidemiological data consistently show postmenopausal women have higher rates of gallstone disease than premenopausal women of a similar age and BMI. The transition itself — not just the final hormonal state — appears to be a period of heightened vulnerability.
Oral Hormone Therapy Raises Gallstone Risk More Than Transdermal
Large observational studies, including data from the Women's Health Initiative, found that oral estrogen therapy was associated with a significantly increased risk of gallbladder disease and cholecystectomy (surgical gallbladder removal). Transdermal estrogen — delivered via patch or gel — appears to carry a meaningfully lower risk, likely because it bypasses first-pass liver metabolism and therefore has less direct effect on hepatic bile production. This is one of several reasons the route of administration matters when considering hormone therapy.
Rapid Weight Changes Common in Perimenopause Can Compound the Risk
The body composition shifts of perimenopause — including increased central adiposity and the weight fluctuations that often accompany it — independently raise gallstone risk, separate from hormonal effects. Rapid weight loss in particular is a well-established gallstone trigger, as it mobilises cholesterol into bile faster than it can be cleared. Women navigating perimenopause who are also managing their weight need to be aware that very-low-calorie approaches can inadvertently spike their gallbladder disease risk.
Symptoms of Gallstones Are Easy to Mistake for Other Menopause Issues
Gallstone pain — typically a dull or cramping ache in the upper right abdomen or between the shoulder blades, often triggered by fatty meals — can be mistaken for bloating, digestive changes, or the general gastrointestinal disruption that is common in perimenopause. Some women also experience nausea, which further blurs the picture. Because gallbladder symptoms can be intermittent and vague, they are easily attributed to other menopause-related gut changes and go uninvestigated for longer than they should.
Lifestyle Levers Exist That Can Meaningfully Lower the Risk
A diet higher in fibre, healthy unsaturated fats, and coffee (yes — coffee has consistent evidence for reducing gallstone risk), combined with moderate physical activity, is associated with lower rates of gallstone formation in postmenopausal women. Maintaining a stable weight rather than cycling through significant losses and regains also appears protective. None of these are guarantees, but they are modifiable factors with a real evidence base — and most of them overlap with the broader lifestyle strategies that support overall menopause health.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.